KLRK1 and pancreatic neoplasm: However, immune suppression and impaired autologous cytotoxicity have been observed among NK cells in patients with pancreatic cancer, and peripheral endogenous NK cells from pancreatic cancer patients had lower expression of the activating ligands NKG2D and NKp30 (8–11).